Huntington's Disease | CHOP Research Institute
 

Huntington's Disease

Published on
Oct 13, 2023
In our weekly news roundup, Dr. Beverly Davidson received a $1 million grant to study Huntington’s disease. This and more on Cornerstone.

Our research on childhood onset neurodegenerative diseases is focused on better understanding the biochemistry and cell biology of proteins deficient in these disorders and developing small molecule or gene therapy-based strategies for therapy.

Dr. Davidson works to understand the molecular basis of childhood onset neurodegenerative diseases and the development of gene and small molecule therapies for treatment. She also focuses on how noncoding RNAs participate in neural development and neurodegenerative disease processes, and how they can be harnessed for therapies.

E-mail:
davidsonbl [at] chop.edu
Published on
May 1, 2018
Researchers gain new insights about dysfunction along an important biological pathway that may impair multiple organ systems in Huntington's disease.
Published on
Jan 12, 2015
Researchers in the Center for Cellular and Molecular Therapeutics (CCMT) at The Children’s Hospital of Philadelphia suggest that an intricate pathway crucial to the development of Huntington’s disease (HD) rests on a “biological teeter-totter” that when carefully balanced could help to control this devastating neurodegenerative disorder.